Tumour ablation: Current role in the liver, kidney, lung and bone

Cancer Imaging

Volumn 8, Issue SPEC. ISS. A, 2008, Pages

  Gillams, Alice ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cryotherapy; Liver tumours; Lung tumours; Microwave; Radiofrequency; Renal cell carcinoma; Tumour ablation

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; ARTICLE; BONE TUMOR; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG TOLERABILITY; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; KIDNEY CARCINOMA; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; LAPAROTOMY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LOW LEVEL LASER THERAPY; LUNG METASTASIS; LUNG TUMOR; MORBIDITY; NEPHRECTOMY; NEPHRON SPARING SURGERY; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREDICTION; RADIOFREQUENCY ABLATION; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; CATHETER ABLATION; COLORECTAL TUMOR; LAPAROSCOPY; LIVER TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; REVIEW;

BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; LIVER NEOPLASMS; LUNG NEOPLASMS; PATIENT SELECTION;

EID: 55949117957     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.9001     Document Type: Article

References (21)

1. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
2. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43: 656-61.
3. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14: 2261-7.
4. Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 2008; 19: 712-7.
5. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-66.
6. Sorensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007; 48: 253-8.
7. Jakobs TF, Hoffmann RT, Trumm C, Reiser MF, Helmberger TK. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 2006; 26: 671-80.
8. Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 2007; 142: 10-9.
9. Mack MG, Straub R, Eichler K, Sollner O, Lehnert T, Vogl TJ. Breast cancer metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004; 233: 400-9.
10. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: 684-92.
11. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-7.
12. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
13. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75-9.
14. Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100: 287-90.
15. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179: 1227-33.
16. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 2007; 62: 639-44.
17. Gillams AR, Lees WR. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 2008; 18: 672-7.
18. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18: 393-8.
19. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13: 1529-37.
20. Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243: 268-75.
21. Callstrom MR, Atwell TD, Charboneau JW, et al. Painful metastases involving bone: percutaneous image-guided cryoablation-prospective trial interim analysis. Radiology 2006; 241: 572-80.